论文部分内容阅读
目的观察辛伐他汀治疗冠心病的临床疗效。方法治疗组在常规治疗基础上,加用辛伐他汀40mg,每晚口服,治疗8周后复查血清总胆固醇(TC),甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)。结果辛伐他订组与对照组比较,血清胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)均有不同程度降低,且减少的肌缺血事件发生。结论辛伐他汀治疗冠心病有明显疗效。
Objective To observe the clinical effect of simvastatin on coronary heart disease. Methods On the basis of conventional treatment, the patients in the treatment group were treated with simvastatin 40 mg orally daily for 8 weeks. The levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL-C) Density lipoprotein (HDL-C). Results Compared with the control group, the levels of serum cholesterol, triglyceride, LDL-C and HDL-C in Simvastatin group decreased to some extent, Reduce the occurrence of ischemic events. Conclusion Simvastatin treatment of coronary heart disease have a significant effect.